RESULTS OF THE USE OF SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR DACLATASVIR FOR CHRONIC HEPATITIS C TREATMENT IN THE REPUBLIC OF BELARUS von Zhavoronok, S. V., Gutmane, V. R., Baryash, T. M., Soldatenko, O. V., Znovets, T. V., Mitsura, V. M., Voropaev, E. V., Gasich, E. L., Yagovdik-Telezhnaja, E. N., Sivachenko, L. V., Anisko, L. A., Zhmurovskaja, L. S., Krapivina, S. V., Yurovskij, N. N., Yurkevich, I. V., Karpov, I. A.

Volltext

CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial von Stebbing, Justin, Prof, Baranau, Yauheni, MD, Baryash, Valeriy, MD, Manikhas, Alexey, MD, Moiseyenko, Vladimir, Prof, Dzagnidze, Giorgi, MD, Zhavrid, Edvard, Prof, Boliukh, Dmytro, MD, Stroyakovskii, Daniil, MD, Pikiel, Joanna, MD, Eniu, Alexandru, MD, Komov, Dmitry, MD, Morar-Bolba, Gabriela, MD, Li, Rubi K, MD, Rusyn, Andriy, Prof, Lee, Sang Joon, PhD, Lee, Sung Young, MS, Esteva, Francisco J, Prof

Volltext

190P3-year follow-up of a phase III trial comparing the efficacy and safety of neoadjuvant and adjuvant trastuzumab and its biosimilar CT-P6 in HER2 positive early breast cancer (E... von Stebbing, J, Baranau, Y, Baryash, V, Manikhas, A, Moiseyenko, V, Dzagnidze, G, Zhavrid, E, Boliukh, D, Stroyakovskiy, D, Pikiel, J, Eniu, A, Komov, D, Lee, S J, Kim, M J, Kim, S, Park, S, Bae, J H, Esteva, F J

Volltext